Form D · Other Health Care

ReviveMed, Inc.

Cambridge, MA · CIK 0001728752

Offering snapshot reported Apr 18, 2018 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 18, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$750K$1.5MJan 31, 2018: $975,000.00Jan 31, 2018Feb 28, 2018: $1,175,000.00Feb 28, 2018Apr 18, 2018: $1,499,998.00Apr 18, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,175,000 → $1,499,998
  • Reported investors8 → 11

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 18, 2018Amendment$1,499,998$324,998vs Feb 28, 201811SEC filing
Feb 28, 2018Amendment$1,175,000$200,000vs Jan 31, 20188SEC filing
Jan 31, 2018Initial$975,000No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-304457

Source: Form D, filed Apr 18, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ernest Fraenkel Director
Carlos Gonzalez Director
Leila Pirhaji Director, Executive
Andrey Zarur Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
700 North Main Street
Cambridge, MA, 02139